M.V.I.-12 (Hospira Worldwide, Inc.)
Welcome to the PulseAid listing for the M.V.I.-12 drug offered from Hospira Worldwide, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira Worldwide, Inc. |
| NON-PROPRIETARY NAME: | retinol, ergocalciferol, .alpha.-tocopherol acetate, dl-, ascorbic acid, niacinamide, riboflavin 5-phosphate sodium, thiamine hydrochloride, pyridoxine hydrochloride, dexpanthenol, biotin, folic acid, |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-01-12 |
| END MARKETING DATE: | 0000-00-00 |
M.V.I.-12 HUMAN PRESCRIPTION DRUG Details:
| Item Description | M.V.I.-12 from Hospira Worldwide, Inc. |
| LABELER NAME: | Hospira Worldwide, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2005-01-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61703-423_e59c5b35-4dc0-4107-aba8-245a34139b95 |
| PRODUCT NDC: | 61703-423 |
| APPLICATION NUMBER: | NDA008809 |